Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedOct 16, 2025
DataAggregated Company Financials
Companies207
  • 7D-2.8%
  • 3M5.2%
  • 1Y-6.4%
  • YTD-0.4%

Over the last 7 days, the Healthcare industry has dropped 2.8%, driven by Chugai Pharmaceutical declining 3.8%. In contrast, Mani has gained 6.7%. However, the industry is down 6.4% over the past year. Earnings are forecast to grow by 9.8% annually.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 16 Oct 2025JP¥65.3tJP¥38.2tJP¥2.7t15.2x24.4x1.7x
Sat, 13 Sep 2025JP¥65.9tJP¥38.2tJP¥2.7t15.7x24.6x1.7x
Mon, 11 Aug 2025JP¥63.2tJP¥38.2tJP¥2.7t15.6x23.7x1.7x
Wed, 09 Jul 2025JP¥60.3tJP¥38.1tJP¥2.6t14.4x22.9x1.6x
Fri, 06 Jun 2025JP¥62.3tJP¥38.1tJP¥2.6t14.2x23.6x1.6x
Sun, 04 May 2025JP¥66.1tJP¥37.8tJP¥2.6t14.8x25.7x1.7x
Tue, 01 Apr 2025JP¥62.2tJP¥37.5tJP¥2.4t14.4x26x1.7x
Thu, 27 Feb 2025JP¥64.8tJP¥37.5tJP¥2.4t15x27.1x1.7x
Sat, 25 Jan 2025JP¥65.9tJP¥36.7tJP¥2.2t16.4x29.5x1.8x
Mon, 23 Dec 2024JP¥66.2tJP¥36.7tJP¥2.2t16.7x29.5x1.8x
Wed, 20 Nov 2024JP¥67.5tJP¥36.7tJP¥2.3t16.7x29.9x1.8x
Fri, 18 Oct 2024JP¥70.4tJP¥36.0tJP¥2.0t17.8x35.5x2x
Sun, 15 Sep 2024JP¥68.5tJP¥36.0tJP¥2.0t17.6x34.5x1.9x
Tue, 13 Aug 2024JP¥67.0tJP¥35.9tJP¥2.0t15.5x33.8x1.9x
Thu, 11 Jul 2024JP¥70.5tJP¥35.1tJP¥1.8t17.8x38.2x2x
Sat, 08 Jun 2024JP¥66.0tJP¥35.3tJP¥1.9t17.7x35.3x1.9x
Mon, 06 May 2024JP¥65.4tJP¥34.9tJP¥2.0t17.3x32.8x1.9x
Wed, 03 Apr 2024JP¥65.6tJP¥35.1tJP¥2.0t17.7x33.5x1.9x
Fri, 01 Mar 2024JP¥68.7tJP¥35.1tJP¥2.0t18.9x35.1x2x
Sun, 28 Jan 2024JP¥65.2tJP¥35.0tJP¥2.2t18.9x30.3x1.9x
Tue, 26 Dec 2023JP¥62.4tJP¥35.0tJP¥2.2t18x29x1.8x
Thu, 23 Nov 2023JP¥63.2tJP¥35.0tJP¥2.2t17.5x29.4x1.8x
Sat, 21 Oct 2023JP¥60.5tJP¥34.5tJP¥2.3t17.3x26.6x1.8x
Mon, 18 Sep 2023JP¥65.6tJP¥34.5tJP¥2.3t18.1x28.9x1.9x
Wed, 16 Aug 2023JP¥64.3tJP¥34.5tJP¥2.3t17.8x28.4x1.9x
Fri, 14 Jul 2023JP¥62.1tJP¥33.9tJP¥2.3t18.2x26.7x1.8x
Sun, 11 Jun 2023JP¥66.3tJP¥33.9tJP¥2.3t18.4x28.6x2x
Tue, 09 May 2023JP¥62.7tJP¥33.7tJP¥2.3t17.7x27.8x1.9x
Thu, 06 Apr 2023JP¥61.0tJP¥33.5tJP¥2.3t16.8x26.5x1.8x
Sat, 04 Mar 2023JP¥59.4tJP¥33.5tJP¥2.3t16.8x25.8x1.8x
Mon, 30 Jan 2023JP¥60.4tJP¥32.4tJP¥2.2t16.1x27.7x1.9x
Wed, 28 Dec 2022JP¥60.1tJP¥32.4tJP¥2.2t15.8x27.6x1.9x
Fri, 25 Nov 2022JP¥65.7tJP¥32.4tJP¥2.2t16.3x30.2x2x
Sun, 23 Oct 2022JP¥62.7tJP¥31.7tJP¥2.3t15.6x27.7x2x
Price to Earnings Ratio

27.7x


Total Market Cap: JP¥62.7tTotal Earnings: JP¥2.3tTotal Revenue: JP¥31.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 29.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.4x which is lower than its 3-year average PE of 29.2x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 5.8% per year over the last three years.
  • Revenues for these companies have grown 6.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market-1.40%
Healthcare-2.79%
Biotech0.62%
Healthcare Services-1.23%
Life Sciences-2.16%
Medical Equipment-2.75%
Pharma-2.96%
Healthtech-4.04%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 75.4x.
    • Analysts are expecting annual earnings growth of 7.1%, which is higher than its past year's earnings growth of 5.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 27% over the next 5 years.
  • However this is lower than its past earnings growth rate of 47% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 7.1% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7730 ManiJP¥1.52k6.7%
+JP¥9.4b		-12.5%PE29.1x
6523 PHC HoldingsJP¥1.03k6.6%
+JP¥8.1b		3.6%PE11.5x
2160 GNI GroupJP¥2.52k5.8%
+JP¥7.6b		-15.3%PS5.8x
219A HeartseedJP¥1.93k11.6%
+JP¥4.6b		27.1%PE84.4x
7780 MeniconJP¥1.18k2.7%
+JP¥2.3b		-23.7%PE18x

Latest News

4519
JP¥7,073.00
Chugai Pharmaceutical
7D
-3.8%
1Y
0.4%

Roche Collaboration And Biologics Pipeline Will Expand Healthcare Reach

Analysts have slightly raised their price target for Chugai Pharmaceutical from ¥8,082 to ¥8,171, citing improved outlooks for revenue growth and profit margins. What's in the News Chugai Pharmaceutical and Eli Lilly announced positive Phase 3 results from the ACHIEVE-3 trial, showing orforglipron delivered superior improvements in glycemic control and weight loss for adults with type 2 diabetes compared to oral semaglutide.
7730
JP¥1,524.00
Mani
7D
6.7%
1Y
-12.5%
4503
JP¥1,603.50
Astellas Pharma
7D
-3.5%
1Y
-7.5%
4568
JP¥4,073.00
Daiichi Sankyo Company
7D
-2.4%
1Y
-17.0%
4592
JP¥2,995.00
SanBio
7D
-22.2%
1Y
191.1%
6523
JP¥1,032.00
PHC Holdings
7D
6.6%
1Y
3.6%

Digital Healthcare And Precision Diagnostics Will Shape Tomorrow

Analysts have raised their price target for PHC Holdings from ¥1,045 to ¥1,209. This change reflects expectations of modest improvements in profit margins, even though revenue growth forecasts are slightly lower and a higher discount rate has been applied.
4502
JP¥4,211.00
Takeda Pharmaceutical
7D
-2.9%
1Y
-0.8%

Pipeline Advances In Rare Diseases Will Revitalize Future Healthcare Markets

Analysts have modestly lowered their price target for Takeda Pharmaceutical, reducing the fair value estimate from ¥5,056.07 to ¥5,002.88. They cite slightly softer outlooks for revenue growth and profit margins as the reason for this adjustment.
219A
JP¥1,925.00
Heartseed
7D
11.6%
1Y
27.1%
4578
JP¥8,153.00
Otsuka Holdings
7D
-3.1%
1Y
-6.9%

These 4 Measures Indicate That Otsuka Holdings (TSE:4578) Is Using Debt Safely

Oct 08
These 4 Measures Indicate That Otsuka Holdings (TSE:4578) Is Using Debt Safely
7780
JP¥1,179.00
Menicon
7D
2.7%
1Y
-23.7%
5038
JP¥2,805.00
eWeLLLtd
7D
4.2%
1Y
71.0%
2413
JP¥2,183.00
M3
7D
-5.8%
1Y
27.5%
2160
JP¥2,515.00
GNI Group
7D
5.8%
1Y
-15.3%
4507
JP¥2,425.50
Shionogi
7D
-4.5%
1Y
17.0%
4554
JP¥1,645.00
Fuji Pharma
7D
4.1%
1Y
25.3%
4889
JP¥2,069.00
Renascience
7D
7.8%
1Y
540.6%